A viral kinetic study using pegylated in
โ
Vassiliki-Anastasia Sypsa; Konstantinos Mimidis; Nicholas C. Tassopoulos; Dimitr
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 428 KB
๐ 2 views
We studied viral dynamic parameters in 44 chronic hepatitis B/hepatitis B e antigen (HBeAg)(ุ) patients treated with pegylated interferon alfa-2b (PEG-IFN) 100 or 200 g weekly or lamivudine 100 mg daily or the combination of PEG-IFN 100 or 200 g with lamivudine. Patients receiving PEG-IFN monotherap